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Abstract. Tumor necrosis factor ~ (TNF) is released systematically during the early phase of endotoxin induced 
fever t. To study the effects of this cytokine in guinea pigs, 2 gg TNF were intra-arterially injected as a bolus or 
slowly infused within 60 rain. Both modes of administration induced a biphasic elevation of the animals' abdominal 
temperature lasting 6 h and stimulated the release of endogenous interleukin-6 (IL-6)-like activity. The second 
phase of the thermal response and the release of endogenous IL-6-1ike activity were significantly higher, when TNF 
was slowly infused into the animals' circulation, in spite of a transiently higher TNF-like activity after the bolus 
injection of TNF. Both TNF and IL-6 may therefore be regarded as candidates to trigger the febrile response in 
guinea pigs. 
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Injection of man or experimental animals with lipo- 
polysaccharide (LPS), a constituent of the gram-nega- 
tive bacterial cell wall, causes fever by stimulating cells 
of the immune system to release cytokines, called en- 
dogenous pyrogens. Circulating tumor necrosis factor 
(TNF) and interleukin-6 (IL-6) associated with those 
cytokines that can be measured in increased amounts 
after administration of LPS ~. Both of these eytokines 
are released into the systemic circulation with very 
characteristic kinetics as determined in rats z,3, ba- 
boons 4,5 and guinea pigs 6. In these species TNF shows a 
transient appearance with a brief, early peak measur- 
able of about 1 h after administration of LPS followed 
by a rapid decline and disappearance from the circula- 
tion. Systemic levels of IL-6 rise to a later peak parallel 
to the febrile changes of body temperature evoked by 
LPS application. Because of these patterns of release of 
cytokines after induction of endotoxemia, TNF has 
been proposed to be one of the initial mediators in the 
cytokine cascade 7,~. The role of TNF in LPS-induced 
fever is, however, not clear and has aroused controversy 
(ref. 1, for review). For example, injection of rabbits 
with small amounts of TNF (1 gg/kg) caused a rather 
short monophasic fever; larger amounts of TNF (10 gg/ 
kg) evoked a much longer biphasie elevation of body 
temperature 9. The authors of that study attributed the 
second peak of the bimodal febrile response to IL-l-like 
activity induced by TNF. It was, however, not shown 
whether the amounts of TNF, which caused fever and 
release of IL-1 in rabbits, corresponded to the levels of 
TNF detected during LPS induced fever. Circulating 
levels of TNF during endotoxemia or TNF infusion and 
corresponding febrile and metabolic responses were 
studied in cancer patients ~~ and were found to be com- 
parable under both conditions. However, injection of 
rats with doses of TNF ranging from 1-50 gg/kg did 
not result in febrile body temperature changes, and 
fevers induced by LPS or 1L-lfl were even attenuated by 
additional injections of TNF 11. Injection of rats with 
TNF-antiserum, which was able to neutralize TNF-like 
bioactivity in rats, 2 h prior to injection of LPS, attenu- 
ated the short initial phase of the febrile response but 
significantly enhanced the longer second phase of the 
bimodal fever 3. These data suggested that TNF may be 
involved in the initiation of the first phase of fever, but 
might then provide a signal for a limitation of the 
second phase of the febrile response and thus act as an 
endogenous antipyretic. 
In two previous studies 6, ~2, we determined bioactivity of 
TNF during LPS induced fevers in guinea pigs based on 
the eytotoxic effect of this cytokine on the mouse 
fibrosarcoma cell line WEHI t64 subclone 13 ~3. In these 
studies peak activity of TNF in blood plasma was 
measured 60 min after injection of LPS with mean val- 
ues of 680 units/ml 6 and 505 units/mP 2, respectively. In 
the present investigation we used a human recombinant 
(hr) TNF preparation with a specific activity of 20,000 
units/gg, also determined by the WEHI bioassay, and 
tried to simulate the peak activity of TNF during LPS 
fever in guinea pigs by intra-arterial injections or infu- 
sions. The effects of these TNF administrations on 
abdominal temperature and systemic IL-6-1ike activity 
were recorded in our experiments. 
Materials and methods 
Animals. This study was performed in 16 male guinea 
pigs with a mean body weight of 465 _+ 12 g at the 
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beginning of the experiments. The animals were housed 
in individual cages at 22 ~ with a 12:12 h light-dark 
cycle (light off at 19.00 h). 
Surgery and sampling of blood plasma. At least one 
week before the start of the experimental procedure, the 
animals were chronically implanted with intra-arterial 
catheters. Guinea pigs were anesthetized with 100 mg/ 
kg ketamine hydrochloride and 4mg/kg xylazin. 
Polyethylene catheters were inserted through the left 
carotid artery until reaching the aortic arch. The distal 
ends of the catheters were tunnelled subcutaneously to 
the interscapular region of the back where they emerged 
through the skin according to the method described by 
Shrader and Everson 14. After implantation, the 
catheters were flushed with sterile heparinized saline 
and closed by heating. During the experiments single 
arterial blood samples (0.5ml) were slowly (within 
1 min) drawn into sterile syringes, put into chilled 
polypropylene tubes and immediately centrifuged. The 
blood plasma was stored at - 7 0  ~ for later determina- 
tion of cytokines. Before the experiments, the animals 
were accustomed to the blood sampling procedure, 
which did not cause excitement or any measurable 
change in body temperature. 
Measurement of body temperature. Abdominal temper- 
ature was measured by use of battery operated 
biotelemetry transmitters (VM-FH-discs, Mini-Mitter 
Co., Sunriver, Oregon, USA) implanted i.p. after place- 
ment of the intra-arterial catheter. Output (frequency in 
Hz) was monitored by a mounted antenna placed under 
each animal's cage (RA 1000 radioreceivers, Mini-Mit- 
ter Co., Sun River, Oregon, USA) and multiplexed by 
means of a BCM 100 consolidation matrix to an IBM 
personal computer system. A Dataquest IV data acqui- 
sition system (Data Sciences Inc., St. Paul, Minnesota, 
USA) was used for automatic control of data collection 
and analysis. Abdominal temperature, which was taken 
as an index of core temperature, was monitored and 
recorded at 5 min intervals. 
Experimental procedure. In a first series of experiments 
8 guinea pigs were intra-arterially injected with 2 pg hr 
TNF dissolved in 0.5 ml sterile pyrogen free saline (spe- 
cific activity 20,000 units/lag; Fa. Biermann GmbH, Bad 
Nauheim, Germany) or with a corresponding volume of 
solvent alone. These two injections were performed 8 
and 16 days after implantation of catheters and 
biotelemetry transmitters. Half of the animals were first 
injected with TNF, the other half with solvent, and 8 
days later vice versa. After the injection the catheters 
were flushed with saline. Blood plasma samples were 
collected in 6 animals 60 min prior to TNF injection as 
well as 1 min, 60 min and 180 rain after TNF injection, 
and assayed for TNF-like and 1L-6-1ike activities. 
In a second series of experiments another group of 8 
guinea pigs were infused i.a. with 2 lag of the same TNF 
preparation (see above) dissolved in 2 ml sterile pyrogen 
free saline or with a corresponding volume of solvent 
alone. The distal end of the catheter was connected by 
polyethylene tubing to a 5 ml glass syringe fixed to an 
infusion pump (Fa. Braun, Melsungen, Germany). The 
infusions lasted 60 min and were performed 8 days and 
16 days after implantation of catheters and biotelemetry 
transmitters. Half of the animals were first infused with 
TNF, the other half with solvent, and 8 days later vice 
versa. At the end of the infusion and prior to samplings 
of blood, the catheters were flushed with saline. Blood 
plasma samples were collected in 6 animals 60 min prior 
to the start of TNF infusion as well as 15 min, 60 rain, 
180 min and 360 rain after the start of TNF infusion, 
assayed for TNF-like and I1-6-1ike activities. 
Bioassay for TNF. Determination of TNF was based 
on the cytotoxic effect of this eytokine on the mouse 
fibrosarcoma cell line WEHI 164 subelone 1313. The 
cells were kindly provided by Dr. A. Waage (University 
of Trondheim, Norway). Plasma samples to be tested 
for TNF were serially diluted in assay medium consist- 
ing of 1% fetal calf serum, 2 mM L-glutamine, 100 U/ml 
penicillin and 100 lag/ml streptomycin in RPMI 1640 
(GIBCO, Long Island, NY, USA), and 100 gl volumes 
were added in triplicate to 96-well tissue culture plates. 
The first sample was 1:10 diluted plasma, which was 
further serially diluted in assay medium 1:20, 1:40, 
1:80, 1:160, 1:320, 1:640, 1:1280 and 1:2560. By this 
wide range of dilutions it was guaranteed that each 
sample was diluted below the detection limit of the 
assay. Cells were washed, resuspended at 500,000 cells/ 
ml in growth medium consisting of 10% fetal calf 
serum, 2raM L-glutamine, 100U/ml penicillin and 
100 lag/ml streptomycin in RPMI 1640, supplemented 
with 10 U/ml sterile heparin and 0.5 gg/ml actinomycin 
D for the assay. 100 pl of cell suspension (50,000 cells) 
was added to each well. The plates were incubated for 
20 h at 37 ~ room air with 5% CO2, and 98% humid- 
ity. Then 20lal of 3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyl-tetrazolium bromide (MTT, 5 mg/ml, Sigma 
Co., St. Louis, Missouri, USA) was added to each well 
to determine the number of living cells (cytotoxicity). 
MTT is a tetrazolium salt that will form dark crystals 
when combined with metabolizing cells. After incuba- 
tion for additional 4 h, 150 gl of supernatant was re- 
moved from each well and 100 ~xl of isopropanol/0.04 m 
HCI was added. The plates were then wrapped in alu- 
minium foil to protect them from light and left at room 
temperature for another 20 h. Then the plates were read 
at 570 nm and 630 nm (for reference) using an EL 312 
Bio-Kinetics reader (BIO-TEK Instruments Inc., 
Winooski, Vermont, USA). The units of TNF were 
calculated based on a purified recombinant human (rh) 
TNF standard run in the same assay with a specific 
activity of 1 U/0.037 ng in the WEHI assay (Cetus, 
Emeryville, California, USA). 100 gl of assay medium 
(see above) containing TNF with activities of 1, 0.5, 0.1, 
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0.05, 0.01, 0.005, 0.001, 0.0005, 0.0001, 0.00005, 
0.00001, 0.000005 and 0.000001 units/lal were used to 
produce a standard curve. From this standard curve, a 
best-fit line was used to calculate TNF activity in the 
plasma samples. We considered any value greater than 
two standard deviations above media containing no 
TNF to be the limit of sensitivity of the assay. For TNF 
this value approximated l U/ml (ref. 3 for further de- 
tails). Since we did not neutralize the measured TNF 
activity in plasma samples, we refer to this activity 
throughout the manuscript as TNF-like activity. 
Bioassay for IL-6. Determination of IL-6 was based on 
the dose-dependent growth stimulation of IL-6 on the 
B 9 cell line, an IL-6 dependent mouse B-cell hybri- 
doma 15. The B 9 cells were kindly provided by Dr. L. 
Aarden (University of Amsterdam, Netherlands). 
Plasma samples to be tested for IL-6 were serially 
diluted in 10% fetal calf serum, 2 m M  L-glutamine, 
100 U/ml penicillin, and 10 Bg/ml streptomycin in Is- 
cove's modified Dulbecco's medium (Sigma Chemical 
Company, St. Louis, Missouri, USA) and 100 lal vol- 
umes were added in triplicate to 96-well tissue culture 
plate. The first sample was 1:10 diluted plasma, which 
was further diluted in assay medium 1:20, 1:50, 1:250, 
1:1250, 1:6250, 1:31250 and 1:56250. Cells were 
washed, resuspended at 50,000 cells/ml in growth 
medium supplemented with 10 U/ml sterile heparin, and 
I00 lal of cell suspension (5,000 cells) was added to each 
well. The plates were incubated for 72 h at 37 ~ room 
air with 5% CO2, and 98% humidity. Then 20 lal of 
MTT (see above) was added to each well to determine 
the number of living cells (cell proliferation). After 
incubation for additional 4 h, 150 lal of supernatant was 
removed and 100 lal of isopropanol/0.04m HC1 was 
added to each well. The plates were protected from light 
and left at room temperature for another 20 h before 
being read at 570 nm and 630 nm (for reference) using 
an EL 312 Bio-kinetics reader (BIO-TEK Instruments 
Inc., Winooski, Vermont, USA). Units were then calcu- 
lated based on a purified rh IL-6 standard run in the 
same assay with a specific activity of 109 U/rag in the 
B 9 assay (Dr. G. Wong, Ginetics Institute, University 
of Los Angeles, California, USA). 100 lal of assay 
medium (see above) containing IL-6 with activities of 
20, 10, 5, 2.5, 1.25, 0.625, 0.3125, and 0.156 units/B1 
were used to produce a standard curve. From this 
standard curve, a best-fit line was used to calculate the 
IL-6 activity in the samples. One unit is defined as the 
amount of IL-6 found to cause half-maximal cell prolif- 
eration in the assay (ref. 2 for further details). Since we 
did not neutralize the measured IL-6 activity in plasma 
samples, we refer to this activity throughout the 
manuscript as IL-6 like activity. 
Evaluation and statistics. In graphs of the thermal re- 
sponses to the injections or infusions of TNF and 
solvent abdominal temperature was plotted over time 
in 15 min intervals. Values were expressed as means _+ 
SEM. Thermal responses were compared by a one-fac- 
tor analysis of variance (ANOVA) followed by Scheffe's 
post-hoc test. IL-6 activities were compared by t-tests or 
t-tests for paired observations when appropriate. 
Results 
Figure 1 summarizes the thermal response of guinea 
pigs to an intra-arterial bolus injection of 2 gg hr TNF 
or solvent. 
Administration of TNF evoked a biphasic elevation of 
abdominal temperature lasting together about 6 h, the 
shorter first phase lasting just about 90 min. Injection of 
saline did not alter the animals' body temperature ap- 
parently. The effects of intra-arterial injections of 2 lag 
hr TNF on circulating levels of TNF-like and IL-6-1ike 
activities are summarized in figure 2. 
Sixty minutes prior to administration of TNF, no TNF- 
like activity was measurable in blood plasma of guinea 
pigs. One minute after an intra-arterial bolus injection 
of 2 Ilg hr TNF with a specific activity of 20,000 units/ 
lag, a circulating TNF-like activity of 2976 + 788 units/ 
ml was detected. Sixty minutes after injection this value 
declined to 255 + 122 units/ml and 2 h later to 43 _+ 15 
units/ml. TNF-like activity could not be detected at any 
stage of the experiment if solvent was injected into the 
animals' circulation. At corresponding stages of the 
experiment, IL-6-1ike activity was 215_+31 units/ml 
60min prior to injection of TNF, 199 +45 units/ml 
1 min after injection, 946 _+ 147 units/ml 60 min after 
injection and 959 _+ 175 units/ml 180 rain after injection 
of TNF. IL-6-1ike activities measured 60min and 
180 min after administration of TNF were significantly 
higher than baseline activity measured 60 min prior to 
the injection (p <0.01 in both cases). In animals in- 
jected with solvent, no apparent changes of IL-6-1ike 
activity in comparison to the baseline values were ob- 
served (158 • 97 units/ml measured 60 min after injec- 
tion, N = 4; 229 -+ 133 units/ml measured 180 min after 
42 
TNF or solvent 
41 
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Figure 1. Thermal responses of guinea pigs (N = 8) to i.a. bolus 
injections of 2 ~tg hr TNF (black symbols) or solvent (open sym- 
bols). Abdominal temperatures are expressed as means, bars 
indicate SEM. 
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Intra-arterial infusions of 2 gg hr TNF evoked a similar 
biphasic elevation of body temperature as observed 
after TNF injection. Infusion of solvent caused just a 
slight increase of abdominal temperature. Between 
120 rain and 300 min after the start of TNF infusion the 
increase in abdominal temperature was significantly 
higher than at the corresponding time intervals after 
bolus injection of TNF (p < 0.001, ANOVA). Levels of 
TNF-tike and IL-6-1ike activities at selected stages of 
the experiment are summarized in figure 4. 
Fifteen minutes after the start of TNF infusion, TNF- 
like activity rose from an undetectable value measured 
60 min prior to the infusion to a value of 339 + 61 units/ 
ml. This value further increased to 438 + 83 units/ml 
measured at the end of i.a. infusion with TNF. Two 
hours later TNF-like activity declined to 56 _+ 7 units/ 
ml, 360 min after start of TNF infusion just 10 _+ 2 
units/ml of TNF-like activity were measured. TNF-like 
activity could not be detected at any stage of the exper- 
iment if solvent was infused into the animals' circula- 
tion. When 2 ~tg hr TNF was infused within 60 rain, a 
much stronger circulating IL-6-1ike activity was induced 
than observed after TNF injection. The baseline level of 
IL-6-1ike activity measured 60 min prior to the start of 
Figure 2. Upper part. TNF-like activity in arterial plasma of  1000 
guinea pigs measured 60 rain before,' and l min, 60 rain and 
180 rain after i.a. bolus injections of  2 lag hr TNF. Columns 
represent means of  6 animals, bars indicate SEM (n.d. = not 800- 
detectable). _. 
Lower part. IL-6-1ike activity in arterial plasma of  guinea pigs E 600- 
measured 60 min before, and 1 min, 60 min and 180 min after i.a. 
bolus-injections of 2 lag hr TNF. Columns represent means of  6 ,, 
animals, bars indicate SEM. ~- 
4 2  
4 1  
40 
1- 
3 9 '  
infusion 
solvent 
3 8  . . . . . . . . . . . . .  ' 9 , 9 
- 120  -60  0 60  120 180 240  3 0 0  360 
t .(min) 
Figure 3. Thermal responses of guinea pigs (N = 8) to i.a. infu- 
sions of 2 gg hr TNF (black symbols) or solvent (open symbols) 
lasting 60 rain, as indicated by arrows. Abdominal temperatures 
are expressed as means, bars indicate SEM. 
injection, N = 4). Since the highest systemic levels of 
TNF-like activity during LPS fever in guinea pigs can 
be observed 60 min after injection of LPS, we adminis- 
tered 2 ~tg hr TNF in the second experiment not as a 
bolus injection but as an i.a. infusion lasting about 
60 min. The influence of i.a. infusions of TNF or sol- 
vent on body temperature are shown on figure 3. 
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Figure 4. Upper part. TNF-like activity in arterial plasma of  
guinea pigs measured 60 min before, and 15 min, 60 rain, 180 min 
and 360 rain after the start of i.a. infusions of  2 ~tg hr TNF lasting 
60 min (n.d. = not detectable). 
Lower part. IL-6-1ike activity in arterial plasma of  guinea pigs 
measured 60 rain before, and 15 min, 60 rain, 180 min and 360 min 
after the start of  i.a. infusions of  2 ~tg hr TNF lasting 60 min. 
Research Articles Experientia 50 (1994), Birkh~user Verlag, CH-4010 Basel/Switzerland 819 
TNF infusion was 305 + 101 units/ml. This value was 
not yet altered 15 rain after the start of TNF infusion 
(291 • 82 units/ml). From this time until the end of the 
infusion, however, however, IL-6-1ike activity rose to 
4382 _+ 696 units.ml. Two hours later 3321 • 792 units/ 
ml of IL-6-1ike activity were measured in arterial 
plasma. Six hours after the start of TNF infusion, 
almost at the end of the increased thermal response, 
IL-6-1ike activity in plasma declined again to 774 • 143 
units/ml. The circulating levels of IL-6-1ike activity mea- 
sured 60 rain and 180 min after the start of TNF infu- 
sion were significantly higher than the baseline value 
(p < 0.001). Sixty minutes (p < 0.001) and 180min 
(p < 0.01) after start of TNF infusion, IL-6-1ike activi- 
ties were significantly higher than 60 min and 180 rain 
after TNF injection. In animals infused with solvent, no 
apparent changes of IL-6-1ike activity in comparison to 
the baseline values were observed (268 • 147 units/ml 
measured 60 min after start of the infusion, N = 4; 
321 • 178 units/ml measured 60 rain after start of the 
infusion, N = 4; 392 _+ 196 units/ml measured 360 rain 
after start of the infusion, N = 3). 
Discussion 
The original interest in TNF mainly arose from its 
selective toxic action on malignant cells. But later on 
much experimental evidence accumulated for the in- 
volvement of TNF in inflammation, cachexia, autoim- 
munity, infectious diseases and septic shock 7. Bacterial 
LPS, which causes fever and can lead to septic shock at 
high doses, is a major inducer of TNF and other im- 
mune mediators called together the cytokine cascade 8. 
TNF has been shown to induce fever after systemic 
administration. There is, however, only one study 
providing experimental evidence that the physiological 
dose of TNF, which transiently appears in the systemic 
circulation during the initial phase of LPS fever, is able 
to induce a febrile response 1~ In the present study we 
tried to inject or infuse amounts of bioactive TNF, 
which correspond to those observed during LPS fever, 
in guinea pigs 6,12. Especially in the second experiment of 
this study, when we infused 40,000 units of TNF within 
60 min, TNF-like bioactivity in plasma was measured 
(438 units/mI) which was not higher than systemic ac- 
tivity of TNF in guinea pigs after i.m. injection of LPS 
(see introduction). The bioactivity of the TNF prepara- 
tion that we used in the present study was tested by the 
same bioassay (WEHI 164 clone 13) which we applied 
for analysis of plasma samples of guinea pigs during 
LPS fever in previous studies 6,a2. Assuming that guinea 
pig TNF-like activity and human recombinant TNF 
have an equimolar bioactivity in the WEHI assay, a 
physiological amount of hr TNF was able to induce a 
biphasic elevation of body temperature and a significant 
increase in systemic IL-6-1ike activity. IL-6 is a cy- 
tokine, which is able to induce fever and synthesis of 
acute-phase proteins 16'~7 and which has been reported to 
be induced by TNF% Therefore, it is not possible to 
decide whether the thermal response to administration 
of TNF was induced by TNF itself, by IL-6 or by any 
other factor induced by TNF or IL-6. Interestingly, 
bolus-injections of 2 gg hr TNF evoked a smaller sec- 
ond fever phase and release of less IL-6-1ike activity 
than a slow infusion of the same amount of TNF, 
although transiently a higher systemic TNF-like activity 
could be observed after the bolus injection. Obviously 
this phenomenon was due to a more rapid inactivation 
of TNF after the bolus injection, while the infusions 
kept TNF-like activity at a constant level for about 
60 rain. Of course, our limited number of samples due 
to the small total blood volume of our experimental 
animal does not allow a description of a complete 
kinetics of injected or infused TNF, but protective inac- 
tivating mechanisms against high circulating levels of 
TNF have been described recently. Thus, in studies in 
man it could be demonstrated that endogenous TNF 
soluble receptors are circulating during experimental 
and clinical inflammation and can protect against exces- 
sive levels of TNF w. It may be that such a protective 
mechanism contributed to the rapid inactivation of 
TNF after the bolus injections. Thus TNF could have 
provided a stronger signal for induction of IL-6-1ike 
activity when it was slowly infused. The fact that higher 
levels of [L-6-1ike activity were accompanied by higher 
thermal responses could support the hypothesis that 
circulating IL-6 provides the febrile signal at least for 
the longer second phase of the bimodal thermal re- 
sponse. This idea remains speculative, however, as long 
as no neutralizing antibodies to guinea pigs' IL-6 are 
available. In addition, it cannot be excluded that i.a. 
administered TNF exerts some direct action on the 
central nervous system; even a small proportion of the 
cytokine could have reached some areas within the 
central nervous system via one or more of the circum- 
ventricular organs. In this way a direct central effect of 
TNF per se could be responsible for the observed ther- 
mal response. 
Interestingly, a baseline IL-6-1ike activity could be de- 
tected in each plasma even before injection or infusion 
of TNF and after injection or infusion of solvent. Could 
this measured IL-6-1ike activity be due to an infection 
or due to the chronic cannulation of the animals? For 
several reasons we do not believe that infection or 
cannulation caused the presence of IL-6 in the systemic 
circulation. First of all, we are aware of how infected 
guinea pigs change their body temperature, body 
weight, motor activity or drinking and eating behavior, 
parameters which are controlled in our experimental 
animals. Also the chronic cannulation can be excluded 
as a reason for the presence of IL-6 because in plasma 
of animals killed by cervical dislocation also, in which 
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blood is sampled via cardiac puncture, baseline levels of  
IL-6 are detectable 2-2~ Even in healthy volunteer hu- 
man subjects, IL-6 can be detected in plasma before 
injection of  an endotoxin 21. The biological significance 
of  the circulating baseline levels of  IL-6 cannot,  how- 
ever, be assessed at present and remains speculative. 
Our  experiments highlight one more par t  of  the so- 
called 'cytokine cascade',  which makes it impossible to 
conclude whether an injected or  infused cytokine is 
truely the natural  media tor  of  fever. I f  T N F  plays a role 
in the cytokine cascade during LPS induced fevers in 
guinea pigs, the contr ibut ion of  this cytokine in induc- 
ing the strong release o f  IL-6-1ike activity after adminis- 
t rat ion of  LPS is rather small. The amount  of  T N F  
which we infused in the present study induced just  
2 - 3 %  of  the IL-6-1ike activity that can be observed 
during LPS fevers in guinea pigs 6,~2. Therefore, the 
intra-arterial  infusion of  T N F  simulated only a small 
par t  of  the physiological responses to LPS injections, 
and the significance of  T N F  in LPS induced fever 
cannot  be judged until we are able to neutralize TNF-  
like activity during LPS fevers completely through 
highly specific antibodies to guinea pigs'  TNF,  which 
are not  available at present. 
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